These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

633 related items for PubMed ID: 29975921

  • 21. circGFRA1 affects the sensitivity of triple-negative breast cancer cells to paclitaxel via the miR-361-5p/TLR4 pathway.
    Zheng SR, Huang QD, Zheng ZH, Zhang ZT, Guo GL.
    J Biochem; 2021 Jul 03; 169(5):601-611. PubMed ID: 33481008
    [Abstract] [Full Text] [Related]

  • 22. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
    Liu X, Tang H, Chen J, Song C, Yang L, Liu P, Wang N, Xie X, Lin X, Xie X.
    Oncotarget; 2015 Aug 21; 6(24):20070-83. PubMed ID: 26036638
    [Abstract] [Full Text] [Related]

  • 23. DNMT1: A key drug target in triple-negative breast cancer.
    Wong KK.
    Semin Cancer Biol; 2021 Jul 21; 72():198-213. PubMed ID: 32461152
    [Abstract] [Full Text] [Related]

  • 24. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2.
    Lv ZD, Yang DX, Liu XP, Jin LY, Wang XG, Yang ZC, Liu D, Zhao JJ, Kong B, Li FN, Wang HB.
    Cell Physiol Biochem; 2017 Jul 21; 44(5):1785-1795. PubMed ID: 29216628
    [Abstract] [Full Text] [Related]

  • 25. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA, Huang WC, Lee WH, Wu A, Wang LS, Hsiao M, Yeh CT, Chao TY.
    BMC Cancer; 2016 Feb 25; 16():160. PubMed ID: 26917489
    [Abstract] [Full Text] [Related]

  • 26. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
    Wu D, Jia H, Zhang Z, Li S.
    Bioorg Chem; 2021 Apr 25; 109():104722. PubMed ID: 33618253
    [Abstract] [Full Text] [Related]

  • 27. miR-155 increases stemness and decitabine resistance in triple-negative breast cancer cells by inhibiting TSPAN5.
    Yang LW, Wu XJ, Liang Y, Ye GQ, Che YC, Wu XZ, Zhu XJ, Fan HL, Fan XP, Xu JF.
    Mol Carcinog; 2020 Apr 25; 59(4):447-461. PubMed ID: 32096299
    [Abstract] [Full Text] [Related]

  • 28. MicroRNA-182 targets FOXF2 to promote the development of triple-negative breast cancer.
    Yu J, Shen W, Gao B, Zhao H, Xu J, Gong B.
    Neoplasma; 2017 Apr 25; 64(2):209-215. PubMed ID: 28043147
    [Abstract] [Full Text] [Related]

  • 29. IMP3 promotes TNBC stem cell property through miRNA-34a regulation.
    Huang QD, Zheng SR, Cai YJ, Chen DL, Shen YY, Lin CQ, Hu XQ, Wang XH, Shi H, Guo GL.
    Eur Rev Med Pharmacol Sci; 2018 May 25; 22(9):2688-2696. PubMed ID: 29771420
    [Abstract] [Full Text] [Related]

  • 30. Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer.
    Tang T, Cheng Y, She Q, Jiang Y, Chen Y, Yang W, Li Y.
    Biomed Pharmacother; 2018 Nov 25; 107():338-346. PubMed ID: 30098551
    [Abstract] [Full Text] [Related]

  • 31. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.
    Xu S, Yue Y, Zhang S, Zhou C, Cheng X, Xie X, Wang X, Lu W.
    J Exp Clin Cancer Res; 2018 Dec 05; 37(1):305. PubMed ID: 30518424
    [Abstract] [Full Text] [Related]

  • 32. Expression of miRNAs Targeting mTOR and S6K1 Genes of mTOR Signaling Pathway Including miR-96, miR-557, and miR-3182 in Triple-Negative Breast Cancer.
    Razaviyan J, Hadavi R, Tavakoli R, Kamani F, Paknejad M, Mohammadi-Yeganeh S.
    Appl Biochem Biotechnol; 2018 Dec 05; 186(4):1074-1089. PubMed ID: 29862445
    [Abstract] [Full Text] [Related]

  • 33. Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis.
    Tao W, Sun W, Zhu H, Zhang J.
    Biochem Biophys Res Commun; 2018 Oct 12; 504(4):629-634. PubMed ID: 30193732
    [Abstract] [Full Text] [Related]

  • 34. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
    Chen H, Pan H, Qian Y, Zhou W, Liu X.
    Mol Cancer; 2018 Jan 08; 17(1):4. PubMed ID: 29310680
    [Abstract] [Full Text] [Related]

  • 35. circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression.
    Chen B, Wei W, Huang X, Xie X, Kong Y, Dai D, Yang L, Wang J, Tang H, Xie X.
    Theranostics; 2018 Jan 08; 8(14):4003-4015. PubMed ID: 30083277
    [Abstract] [Full Text] [Related]

  • 36. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
    Liu H, Wang Y, Li X, Zhang YJ, Li J, Zheng YQ, Liu M, Song X, Li XR.
    Tumour Biol; 2013 Jun 08; 34(3):1713-22. PubMed ID: 23430586
    [Abstract] [Full Text] [Related]

  • 37. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.
    Al-Marsoummi S, Vomhof-DeKrey E, Basson MD.
    Cell Physiol Biochem; 2019 Jun 08; 53(6):999-1014. PubMed ID: 31838790
    [Abstract] [Full Text] [Related]

  • 38. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10.
    Liu F, Zhuang L, Wu R, Li D.
    J BUON; 2019 Jun 08; 24(5):1905-1912. PubMed ID: 31786854
    [Abstract] [Full Text] [Related]

  • 39. [Knock-down of BCL11A expression in breast cancer cells promotes MDA-MB-231 cell apoptosis].
    Li H, Gui C, Yan L.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Nov 08; 32(11):1532-1535. PubMed ID: 27774950
    [Abstract] [Full Text] [Related]

  • 40. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L, Nuncia-Cantarero M, Morcillo-Garcia S, Nieto-Jimenez C, Burgos M, Corrales-Sanchez V, Perez-Peña J, Győrffy B, Ocaña A, Galán-Moya EM.
    Cell Oncol (Dordr); 2020 Jun 08; 43(3):431-444. PubMed ID: 32166583
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.